A Novel Fluorescent and Bioluminescent Bireporter Influenza A Virus To Evaluate Viral Infections.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
15 05 2019
Historique:
received: 08 01 2019
accepted: 04 03 2019
pubmed: 15 3 2019
medline: 3 3 2020
entrez: 15 3 2019
Statut: epublish

Résumé

Studying influenza A virus (IAV) requires the use of secondary approaches to detect the presence of virus in infected cells. To overcome this problem, we and others have generated recombinant IAV expressing fluorescent or luciferase reporter genes. These foreign reporter genes can be used as valid surrogates to track the presence of virus. However, the limited capacity for incorporating foreign sequences in the viral genome forced researchers to select a fluorescent or a luciferase reporter gene, depending on the type of study. To circumvent this limitation, we engineered a novel recombinant replication-competent bireporter IAV (BIRFLU) expressing both fluorescent and luciferase reporter genes. In cultured cells, BIRFLU displayed growth kinetics comparable to those of wild-type (WT) virus and was used to screen neutralizing antibodies or compounds with antiviral activity. The expression of two reporter genes allows monitoring of viral inhibition by fluorescence or bioluminescence, overcoming the limitations associated with the use of one reporter gene as a readout.

Identifiants

pubmed: 30867298
pii: JVI.00032-19
doi: 10.1128/JVI.00032-19
pmc: PMC6498038
pii:
doi:

Substances chimiques

Antiviral Agents 0
Luminescent Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI141607
Pays : United States

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

PLoS Pathog. 2007 May 11;3(5):e61
pubmed: 17500589
Curr Protoc Microbiol. 2013;Chapter 15:Unit 15G.4
pubmed: 23686828
J Virol. 2015 Mar;89(6):2990-4
pubmed: 25540375
J Virol. 2014 Jan;88(2):878-89
pubmed: 24198417
Nature. 2009 Jun 25;459(7250):1122-5
pubmed: 19516283
J Virol Methods. 1998 Sep;74(1):57-66
pubmed: 9763129
J Cell Sci. 2007 Dec 15;120(Pt 24):4247-60
pubmed: 18057027
Nat Biotechnol. 2005 Jan;23(1):102-7
pubmed: 15580262
Mol Imaging. 2013 Oct;12(7):1-13
pubmed: 24371848
PLoS One. 2010 Feb 22;5(2):e9332
pubmed: 20179772
Emerg Infect Dis. 2006 Jan;12(1):9-14
pubmed: 16494710
Drugs. 2018 Sep;78(13):1297-1308
pubmed: 30088204
MMWR Recomm Rep. 2016 Aug 26;65(5):1-54
pubmed: 27560619
J Virol. 2013 Aug;87(15):8272-81
pubmed: 23698304
Sci Rep. 2018 Mar 12;8(1):4374
pubmed: 29531320
Curr Opin Pharmacol. 2012 Oct;12(5):592-600
pubmed: 22954534
Vaccine. 2007 Jun 28;25(27):5086-96
pubmed: 17544181
J Gen Virol. 2008 Oct;89(Pt 10):2359-2376
pubmed: 18796704
Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1965-73
pubmed: 11779399
Sci Rep. 2017 Sep 7;7(1):10857
pubmed: 28883436
Nat Methods. 2005 Dec;2(12):905-9
pubmed: 16299475
Methods Mol Biol. 2018;1836:59-88
pubmed: 30151569
Antimicrob Agents Chemother. 2009 Oct;53(10):4115-26
pubmed: 19620324
J Infect Dis. 2018 Jun 20;218(2):176-178
pubmed: 29361111
PLoS One. 2014 May 19;9(5):e97695
pubmed: 24842154
mBio. 2017 May 30;8(3):
pubmed: 28559489
J Virol. 2013 Dec;87(24):13321-9
pubmed: 24089552
J Virol. 2010 Dec;84(24):12761-70
pubmed: 20926573
Cold Spring Harb Protoc. 2012 Aug 01;2012(8):
pubmed: 22854570
PLoS One. 2017 Nov 16;12(11):e0188267
pubmed: 29145498
Sci Rep. 2015 Jun 12;5:11346
pubmed: 26068081
Diagn Microbiol Infect Dis. 2010 Nov;68(3):214-9
pubmed: 20955912
EMBO J. 1985 Nov;4(11):3021-4
pubmed: 4065098
Vaccine. 2018 Oct 15;36(43):6383-6392
pubmed: 30224200
PLoS One. 2015 Aug 04;10(8):e0133888
pubmed: 26241861
Int J Mol Sci. 2016 Dec 22;18(1):
pubmed: 28025504
Clin Microbiol Rev. 2013 Jul;26(3):476-92
pubmed: 23824369
PLoS Pathog. 2010 Jan 29;6(1):e1000745
pubmed: 20126449
Nat Med. 2014 Feb;20(2):143-51
pubmed: 24412922
Nat Commun. 2015 Mar 25;6:6600
pubmed: 25807527
Virus Res. 2016 May 2;216:26-40
pubmed: 26220478
Emerg Infect Dis. 2006 Jan;12(1):15-22
pubmed: 16494711
J Virol. 2015 Mar;89(6):3421-6
pubmed: 25552727
J Infect Dis. 2013 Nov;208 Suppl 2:S137-44
pubmed: 24151320
Annu Rev Microbiol. 2005;59:553-86
pubmed: 16153179
Vaccine. 2015 Jul 9;33(30):3562-70
pubmed: 26044496
J Virol. 2010 Feb;84(4):2157-63
pubmed: 19939917
Cell Host Microbe. 2010 Jun 25;7(6):440-51
pubmed: 20542248
Science. 1972 Aug 25;177(4050):705-6
pubmed: 4340949
Viruses. 2015 Oct 13;7(10):5319-27
pubmed: 26473913
PLoS One. 2018 Sep 7;13(9):e0202787
pubmed: 30192781
PLoS One. 2016 Jan 25;11(1):e0147723
pubmed: 26809059
Antiviral Res. 2008 Apr;78(1):91-102
pubmed: 18328578
J Infect. 2011 Jan;62(1):14-25
pubmed: 20950645
Nat Commun. 2015 Mar 06;6:6378
pubmed: 25744559
Euro Surveill. 2008 Jan 31;13(5):
pubmed: 18445375
PLoS Pathog. 2013;9(10):e1003657
pubmed: 24130481
Lancet Infect Dis. 2012 Jan;12(1):36-44
pubmed: 22032844
N Engl J Med. 2018 Jan 4;378(1):7-9
pubmed: 29185857
Virus Res. 2016 Feb 2;213:69-81
pubmed: 26590325
JAMA. 2009 Mar 11;301(10):1034-41
pubmed: 19255110
mBio. 2017 Jun 6;8(3):
pubmed: 28588131
Virology. 2015 Feb;476:206-216
pubmed: 25553516
J Virol. 2014 Sep;88(18):10525-40
pubmed: 24965472
J Virol. 2010 Nov;84(21):11219-26
pubmed: 20739532
Vaccine. 2009 Dec 10;28(1):228-34
pubmed: 19796721
Anal Chem. 2018 Aug 7;90(15):9583-9590
pubmed: 29985597
Vaccine. 2010 Feb 3;28(5):1156-67
pubmed: 20004635
Science. 2000 Nov 24;290(5496):1585-8
pubmed: 11090358
Nat Immunol. 2010 May;11(5):427-34
pubmed: 20305659
ACS Chem Biol. 2012 Nov 16;7(11):1848-57
pubmed: 22894855
Antiviral Res. 2009 Sep;83(3):290-7
pubmed: 19591877
J Virol. 2012 Feb;86(3):1433-48
pubmed: 22114331
Hum Vaccin Immunother. 2016 Sep;12(9):2269-77
pubmed: 27184622
Curr Top Microbiol Immunol. 2015;386:301-21
pubmed: 25007847
J Biomed Opt. 2005 Jul-Aug;10(4):41210
pubmed: 16178634
Vaccine. 2017 Oct 9;35(42):5708-5713
pubmed: 28890196
J Vis Exp. 2013 Jun 16;(76):e50363
pubmed: 23793043
J Virol. 2016 Jun 24;90(14):6291-6302
pubmed: 27122587
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11531-6
pubmed: 20534532
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4269-74
pubmed: 22371588
Viruses. 2016 Jun 23;8(7):
pubmed: 27347991

Auteurs

Aitor Nogales (A)

Department of Microbiology and Immunology, University of Rochester, Rochester, New York, USA.
Center for Animal Health Research, INIA-CISA, Madrid, Spain.

Gines Ávila-Pérez (G)

Department of Microbiology and Immunology, University of Rochester, Rochester, New York, USA.

Javier Rangel-Moreno (J)

Division of Allergy/Immunology and Rheumatology, Department of Medicine, University of Rochester, Rochester, New York, USA.

Kevin Chiem (K)

Department of Microbiology and Immunology, University of Rochester, Rochester, New York, USA.

Marta L DeDiego (ML)

Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain.

Luis Martínez-Sobrido (L)

Department of Microbiology and Immunology, University of Rochester, Rochester, New York, USA luis_martinez@urmc.rochester.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH